PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer&apos;s disease progression in Down syndrome

Aging and Cognitive Functions

Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease

Brain.

Shinohara M, Koga S, Konno T, Nix J, Shinohara M, Aoki N, Das P, Parisi JE, Petersen RC, Rosenberry TL, Dickson DW, Bu G

doi: 10.1093/brain/awx284.

Aging and Cognitive FunctionsAlzheimer’s Disease

Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology

JAMA Neurol.

Schreiber S, Schreiber F, Lockhart SN, Horng A, Bejanin A, Landau SM, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative

doi: 10.1001/jamaneurol.

Aging and Cognitive Functions

High performance plasma amyloid-β biomarkers for Alzheimer's disease

Nature

Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, Iwamoto S, Ito K, Tanaka K, Masters CL, Yanagisawa K

doi: 10.1038/nature25456.

Aging and Cognitive FunctionsAlzheimer’s DiseaseDementia

Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease

JAMA Neurol.

Quiroz YT, Sperling RA, Norton DJ, Baena A, Arboleda-Velasquez JF, Cosio D, Schultz A, Lapoint M, Guzman-Velez E, Miller JB, Kim LA, Chen K, Tariot PN, Lopera F, Reiman EM, Johnson KA

doi: 10.1001/jamaneurol.

Alzheimer’s Disease

Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

Lancet.

Fortea J, Vilaplana E, Carmona-Iragui M, Benejam B, Videla L, Barroeta I, Fernández S, Altuna M, Pegueroles J, Montal V, Valldeneu S, Giménez S, González-Ortiz S, Muñoz L, Estellés T, Illán-Gala I, Belbin O, Camacho V, Wilson LR, Annus T, Osorio RS, Videla S, Lehmann S, Holland AJ, Alcolea D, Clarimón J, Zaman SH, Blesa R, Lleó A

doi: 10.

Aging and Cognitive FunctionsDementia

Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression

J Alzheimers Dis.

Scheltens NME, Tijms BM, Heymans MW, Rabinovici GD, Cohn-Sheehy BI, Miller BL, Kramer JH, Wolfsgruber S, Wagner M, Kornhuber J, Peters O, Scheltens P, van der Flier WM, Amsterdam Dementia Cohort, Alzheimer’s Disease Neuroimaging Initiative, German Dementia Competence Network, University of San Francisco Memory and Aging Center

doi: 10.3233/JAD-171088.

Aging and Cognitive FunctionsAlzheimer’s Disease

Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease

Neurology.

McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier K, Xiong C, Allegri R, Berman SB, Klunk W, Noble J, Ringman J, Ghetti B, Farlow M, Sperling RA, Chhatwal J, Salloway S, Graff-Radford NR, Schofield PR, Masters C, Rossor MN, Fox NC, Levin J, Jucker M, Bateman RJ, Dominantly Inherited Alzheimer Network

doi: 10.1212/

Alzheimer’s Disease

Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury

J Alzheimers Dis.

DeCarli C, Villeneuve S, Maillard P, Harvey D, Singh B, Carmichael O, Fletcher E, Olichney J, Farias S, Jagust W, Reed B, Mungas D

doi: 10.3233/JAD-

Alzheimer’s Disease

Evolution of anosognosia in Alzheimer's disease and its relationship to amyloid

Ann Neurol.

Hanseeuw BJ, Scott MR, Sikkes S, Properzi M, Gatchel J, Salmon E, Marshall GA, Vannini P, Alzheimer's Disease Neuroimaging Initiative.

doi: 10.1002/ana.25649.

Neurology · Psychiatry

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome

Related content

Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease

Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology

High performance plasma amyloid-β biomarkers for Alzheimer's disease

Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease

Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression

Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease

Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury

Evolution of anosognosia in Alzheimer's disease and its relationship to amyloid